September 20, 2023 – POCTA leads letter to the Centers for Medicare and Medicaid Services (CMS) encourage the agency to instruct State Medicaid programs to recognize and process claims submitted with Proprietary Laboratory Analysis (“PLA”) codes established by the American Medical Association’s Current Procedural Terminology (“CPT”) Editorial Panel. Individual states’ continued refusal to recognize PLA codes unnecessarily restricts Medicaid beneficiaries’ access to the tests described by these codes (such as EUA-authorized tests for SARS-Cov-2, FDA-approved companion diagnostics for advanced cancer therapies, and other novel, innovative tests) and is not consistent with existing law.